Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -195,795 | -246,416 | -221,102 | -165,164 | -81,355 |
| Depreciation Amortization | 2,229 | -863 | 3,362 | 5,108 | 1,002 |
| Accounts payable and accrued liabilities | -307 | -992 | -3,002 | 652 | 2,198 |
| Other Working Capital | -7,105 | -6,693 | 155,170 | 6,447 | 2,045 |
| Other Operating Activity | 47,982 | 62,733 | 59,719 | 27,975 | 8,229 |
| Operating Cash Flow | $-152,996 | $-192,231 | $-5,853 | $-124,982 | $-67,881 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,813 | -12,381 | -10,206 | -13,244 | -17,502 |
| Purchase Of Investment | -219,427 | -365,039 | -540,022 | -128,705 | -207,986 |
| Sale Of Investment | 289,398 | 445,775 | 324,584 | 157,410 | 283,777 |
| Investing Cash Flow | $64,158 | $68,355 | $-225,644 | $15,461 | $58,289 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,460 | 115,068 | 219,382 | 4,031 | 216,512 |
| Other Financing Activity | -72 | 0 | 0 | -1,555 | -1,731 |
| Financing Cash Flow | $2,388 | $115,068 | $219,382 | $2,476 | $214,781 |
| Beginning Cash Position | 113,112 | 121,920 | 134,035 | 241,080 | 35,891 |
| End Cash Position | 26,662 | 113,112 | 121,920 | 134,035 | 241,080 |
| Net Cash Flow | $-86,450 | $-8,808 | $-12,115 | $-107,045 | $205,189 |
| Free Cash Flow | |||||
| Operating Cash Flow | -152,996 | -192,231 | -5,853 | -124,982 | -67,881 |
| Capital Expenditure | -5,852 | -12,381 | -10,206 | -13,244 | -17,502 |
| Free Cash Flow | -158,848 | -204,612 | -16,059 | -138,226 | -85,383 |